Author

Robert Genta 1

1 Baylor College of Medicine,Houston,United States

Efficacy and Safety of AK002 in Adult Patients with Active Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis: Primary Results from a Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial (ENIGMA Study)

Evan S Dellon, Kathryn Peterson, Joseph A. Murray, Gary W. Falk, Nirmala Gonsalves, Mirna Chehade, John Leung, Robert Genta, Marc E. Rothenberg, Paneez Khoury, Adam Bledsoe, Camilla Shaw, Henrik Rasmussen, BHUPINDER SINGH, Alan Chang, Amol Kamboj, Ikuo Hirano

HIGH DISCOVERY RATE OF EOSINOPHILIC GASTRITIS AND/OR DUODENITIS AMONG PATIENTS WITH CHRONIC FUNCTIONAL GASTROINTESTINAL SYMPTOMS

Amol Kamboj, Nicholas J. Talley, William Chey, Henrik Rasmussen, Kathryn Peterson, Mirna Chehade, Brian Lacy, Ikuo Hirano, Anthony J. Lembo, Colleen Schmitt, Marc E. Rothenberg, Robert Genta, Neal Jain, Maria Pletneva, Cory Mekelburg, Evan S. Dellon, William J. Sandborn, Nirmala Gonsalves, Kevin Turner, Malika Pasha

SAFETY AND EFFICACY OF LONG-TERM TREATMENT WITH LIRENTELIMAB, A MONOCLONAL ANTIBODY AGAINST SIGLEC-8, IN PATIENTS WITH EOSINOPHILIC GASTRITIS/DUODENITIS

Evan S. Dellon, Kathryn Peterson, Joseph A. Murray, Gary W. Falk, Nirmala Gonsalves, Robert Genta, John Leung, Paneez Khoury, Amy Klion, Sabine Hazan, Michael F. Vaezi, Adam Bledsoe, Sandy Durrani, Chao Wang, Camilla Shaw, Alan Chang, BHUPINDER SINGH, Amol Kamboj, Henrik Rasmussen, Marc E. Rothenberg, Ikuo Hirano, Mirn

Item 1 - 3 / 3
1